Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

NATURALLY OCCURRING ALTERNATIVE TREATMENT MODEL OF CHLOROQUINE/HYDROXYCHLOROQUINE + AZITHROMYCIN + ANTIALLERGIC MEDICATIONS EFFECTIVE IN COVID-19 SUSPECTED SYMPTOMATIC PATIENTS: AN INDIAN PERSPECTIVE

  Authors

  Dr. Dipankar Bhattacharyya

  Keywords

COVID-19, CQ/HCQ: reposition and side effects, reposition of other drugs, SITBP/S and CBTT treatment model

  Abstract


Whole world is fighting against single enemy, novel corona virus (nCoV) causing respiratory trouble, the disease originated from Wuhan of China at the end of 2019 (COVID-19) which is very much similar with the corona virus causing severe acute respiratory syndrome, the disease outbrocken in 2003 (SARS). That is why nCoV is also called SARS-CoV-2/2019-nCoV. Present world is exhausted under massive lockdown and becoming looser day by day. No specific treatment yet to be established except repositioning of some old drugs, though they possess risky side effects. At this juncture to overcome adverse side effects of such drugs, aiming to search naturally occuring candidates targetting to establish a treatment model and to combat the challenge. The traditional plants/spices of bitter taste from Indian origin like Azadirachta indica A. Juss. (Indian Lilac/Neem/Nimtree), Andrographis paniculata (Burm. f.) Nees (green chirata/Indian kalmegh), Momordica charantia L. (bitter gourd/bitter melon/Indian karela), Moringa oleifera Lam. (Tree of life/Miracle-/Drumstick-/Horseradish tree), Curcuma longa L. (turmeric/Indian Haridra) rhizome and Nigella sativa L. (Black Cumin/Kalonji/Indian Kalojeera) seeds commonly pose the antimalarial, antidiabetic, antihyperlipidemic, anti-inflammatory/antiarthritic, immunomodulatory, and antiviral bioactive behaviors as therapeutics. Chloroquine/Hydroxychloroquine are resembled the same behaviors concomitantly. Both chloroquine(CQ) and hydroxychloroquine(HCQ) are synthetic antimalarial and antiarthritic drugs but recently repurposing the antiviral activity against SARS-CoV-2. CQ exhibits adverse side effects like vision loss, psychiatric disorder, cramp etc.. But HCQ, hydroxylated derivative of CQ is less toxic than CQ. HCQ on the other hand, it has been linked to some instances of cardiac arrhythmia, macular disorder and liver damage. Present study aiming to evaluate naturally occuring preventive/prophylactic/alternative potentials from Indian perspective searching database from existing literature and internets to overcome such odd side effects of CQ/HCQ on human subjects. The common/signature bioactive behaviors of some Indian traditional bitter plants/spices (SITBP/S) mentioned above and CQ/HCQ are more or less are found to be similar. Moreover SITBP/S exhibits anthelmintic and antiulcer good effects found from literature. Also a di-/tri-/polyherbal formulation could be suggested by constructing a Common base-tetra-triangular (CBTT) model for traditional treatment thus proposed and implimented on a very small group of COVID-19 suspected symptomatic patients from my Instititute at preliminary level, especially as preventive/prophylactic or alternative antiviral approach to SARS-CoV-2, might be rationalized to replace the CQ/HCQ side effective treatment. CBTT model of treatment + azithromycin (AZ) were implimented in presence or absence of antiallergic medications (AAMs) in symptomatic patients those who were denied to go Hospital. Without the AAMs, 7 days delay of recovery was observed. Resulting CBTT model +AZ + AAMs could be repurposed for faster recovery.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2007194

  Paper ID - 196548

  Page Number(s) - 2149-2184

  Pubished in - Volume 8 | Issue 7 | July 2020

  DOI (Digital Object Identifier) -    http://doi.one/10.1729/Journal.25258

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Dr. Dipankar Bhattacharyya,   "NATURALLY OCCURRING ALTERNATIVE TREATMENT MODEL OF CHLOROQUINE/HYDROXYCHLOROQUINE + AZITHROMYCIN + ANTIALLERGIC MEDICATIONS EFFECTIVE IN COVID-19 SUSPECTED SYMPTOMATIC PATIENTS: AN INDIAN PERSPECTIVE ", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.8, Issue 7, pp.2149-2184, July 2020, Available at :http://www.ijcrt.org/papers/IJCRT2007194.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper May 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer